Learn More About the Cardinal Clinical Trial in This Free Web Seminar
It’s not often that patients get to hear about a clinical trial directly from its sponsoring company’s CEO — but that’s exactly what Reata Pharmaceuticals is offering. Reata is now starting the Phase 3 part of its CARDINAL clinical trial, which is evaluating the safety and efficacy of bardoxolone methyl…